Clinical Trials Directory

Trials / Unknown

UnknownNCT04649320

Perception of the COVID-19 Pandemic in Patients With Haematological or Solid Neoplasias

Investigation of the Perception of the COVID-19 Pandemic in Patients With Haematological or Solid Neoplasias Using Patient-reported Outcome Measures (PROMs)

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Medical University Innsbruck · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cancer patients are among the most vulnerable individuals, whose health-related quality of life (HRQOL) may be substantially impacted by the COVID19 pandemic. We want to study how the COVID-19 pandemic influences the life of cancer patients and how these patients cope with the additional distress with the aim to facilitate the development of improved future interventional strategies to maintain resilience and HRQOL

Detailed description

In December 2019, the novel human pathogenic virus "SARS-CoV2" from the coronavirus family was identified, causing a respiratory disease known as "COVID19" (coronavirus disease 2019). COVID19 manifests itself primarily with influenza-like symptoms, but in special cases it can lead to severe conditions such as ARDS (acute respiratory distress syndrome). Compared to other pulmotropic viruses such as the influenza virus, SARS-CoV-2 is associated with a higher contagiousness and mortality. Haematological and oncological patients are particularly vulnerable due to their advanced age, immunological restrictions in the context of the underlying disease and the treatment modalities (chemotherapy, radiation therapy, ...). To evaluate the effects of the COVID19 pandemic on the perception of patients with malignant diseases, we aim to record so-called "patient-reported outcomes" (PROs) from patients at the University Hospital of Innsbruck at the Department of Internal Medicine V (Hematology and Oncology) and at the Department for Radiotherapy and Radiation Oncology. We use the validated EORT QLQ-C30 and a specially developed questionnaire for COVID19.

Conditions

Interventions

TypeNameDescription
OTHERquestionnaire1. 13-item questionnaire about cancer patient's distress and everyday life, 2. EORTC-QLQ-C30

Timeline

Start date
2020-11-23
Primary completion
2020-12-31
Completion
2020-12-31
First posted
2020-12-02
Last updated
2020-12-02

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT04649320. Inclusion in this directory is not an endorsement.